Acadian Asset Management’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,722
| Closed | -$234K | – | 2122 |
|
|
2024
Q3 | $234K | Buy |
+10,722
| New | +$234K | ﹤0.01% | 1308 |
|
|
2020
Q3 | – | Sell |
-49,257
| Closed | -$146K | – | 2341 |
|
|
2020
Q2 | $146K | Sell |
49,257
-41,016
| -45% | -$122K | ﹤0.01% | 1603 |
|
|
2020
Q1 | $214K | Sell |
90,273
-40,039
| -31% | -$94.9K | ﹤0.01% | 1183 |
|
|
2019
Q4 | $208K | Sell |
130,312
-43,073
| -25% | -$68.8K | ﹤0.01% | 1286 |
|
|
2019
Q3 | $310K | Hold |
173,385
| – | – | ﹤0.01% | 1209 |
|
|
2019
Q2 | $220K | Sell |
173,385
-2,115
| -1% | -$2.68K | ﹤0.01% | 1201 |
|
|
2019
Q1 | $321K | Sell |
175,500
-7,660
| -4% | -$14K | ﹤0.01% | 1231 |
|
|
2018
Q4 | $210K | Buy |
183,160
+10,208
| +6% | +$11.7K | ﹤0.01% | 1103 |
|
|
2018
Q3 | $384K | Buy |
172,952
+66,447
| +62% | +$148K | ﹤0.01% | 940 |
|
|
2018
Q2 | $261K | Sell |
106,505
-30,417
| -22% | -$74.5K | ﹤0.01% | 1018 |
|
|
2018
Q1 | $1.77M | Sell |
136,922
-7,161
| -5% | -$92.4K | 0.01% | 612 |
|
|
2017
Q4 | $1.6M | Buy |
144,083
+94,876
| +193% | +$1.05M | 0.01% | 596 |
|
|
2017
Q3 | $618K | Buy |
49,207
+36,356
| +283% | +$457K | ﹤0.01% | 755 |
|
|
2017
Q2 | $145K | Buy |
12,851
+1
| +0% | +$11 | ﹤0.01% | 989 |
|
|
2017
Q1 | $171K | Buy |
+12,850
| New | +$171K | ﹤0.01% | 1066 |
|